However, the mechanism by which ROS activates Stat3 in BM-MSCs in response to breast tumor-mimicking conditions and the mechanism by which ROS and JAK/Stat3 increase HIF-1α expression remain unclear and must be further investigated. This evidence concerns the gene STAT3 and breast neoplasm.